Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced a private placement of not more than 61,951,700 A shares for gross proceeds of not more than CNY 300,000,000 on April 28, 2023. The transaction will include participation from not more than 35 investors. The shares have a hold period of 6 months from the issuance closing date.

The transaction has been approved at the 19th meeting of the 3rd directorate of the company. The transaction still needs to be approved by the Shenzhen Stock Exchange and the China Securities Regulatory Commission.